Searching in epo · Search everything

Clear filters

5 changes Guidance, last 7 days

Favicon for changeflow.com

Method for Seed Genetic Purity Estimation and Cross-Pollination Detection

The European Patent Office has published patent application EP4712001A1 for a method and system developed by Tata Consultancy Services Limited for estimating seed genetic purity and detecting cross-pollination. The system utilizes remote sensing, weather, historical, and soil data to calculate contamination scores and assess crop characteristics.

Routine Guidance Agriculture
Favicon for changeflow.com

Medical Data Display Method Patent Application

The European Patent Office published a patent application by Shining 3D Tech Co., Ltd. for a medical data display method. The method aligns medical data from multiple device sources and time nodes to improve data presentation efficiency for users.

Routine Guidance Healthcare
Favicon for changeflow.com

Siemens Healthineers AI Radiotherapy Modulation Patent EP4711001A1

The European Patent Office has published patent EP4711001A1 for Siemens Healthineers, detailing systems and methods that use artificial intelligence to control modulation in radiotherapy plans. This patent aims to optimize treatment planning by incorporating AI-driven dose distribution and regularization factors.

Routine Guidance Healthcare
Favicon for changeflow.com

Pyridazinone Compounds as Thyroid Hormone Analogs Synthesis Methods

The European Patent Office has published a patent application detailing new synthesis methods for pyridazinone compounds, which act as thyroid hormone analogs. These methods aim to improve purity, yield, and scalability for large-scale preparation, and also describe morphic forms and a treatment method for thyroid hormone resistance.

Routine Guidance Pharmaceuticals
Favicon for changeflow.com

Fused Pyrrole/Pyridine Compound for Myt1 Inhibitor Cancer Treatment

The European Patent Office has published patent application EP4711364A1 for Pharmaengine, Inc., detailing a fused pyrrole or pyridine ring compound for use as a Myt1 inhibitor in cancer treatment. The publication includes the compound's formula, its use in a pharmaceutical composition, and a method for its preparation.

Routine Guidance Pharmaceuticals

Get alerts for ""

We'll email you when new changes match this search.

Free. Unsubscribe anytime.